Aprea Therapeutics, Inc. - COM NEW (APRE)

Historical Portfolio Holders from Q1 2023 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q2 2024
2.08M
Holdings value Q2 2024
$8.47M
Value change Q2 2024
+$1.87M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
26
Number of buys Q2 2024
11
Number of sells Q2 2024
-5
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 2.08M $8.47M +$1.87M $4.07 26
2024 Q1 1.62M $10.8M +$4.97M $6.69 21
2023 Q4 926K $4.35M +$26.6K $4.70 19
2023 Q3 876K $3.66M -$19.5K $4.17 19
2023 Q2 881K $2.77M +$102K $3.15 17
2023 Q1 848K $3.77M +$3.77M $4.44 16